An add-on strategy that compounded value across a four-year sponsor hold

The sponsor had acquired the platform with a clear thesis: that the specialty chemicals segment in which it operated was fragmented, that consolidation was inevitable, and that the platform's manufacturing footprint and regulatory expertise made it the natural acquirer of regional players. Eighteen months into the hold, the thesis was largely intact and largely unexecuted. Two attempted add-ons had not closed. The internal corporate-development capacity was thin, and the operating team — competent and committed — was understandably absorbed in running the base business.

The sponsor retained Halverson Reed to do three things: validate the consolidation thesis against a refreshed view of the segment, build a defensible target list with practical paths to engagement, and accompany the platform through the diligence and integration of any transactions that resulted.

We began with a four-week diagnostic. The consolidation thesis survived contact with the refreshed market view, with one important refinement: two of the segment's geographies were already substantially picked over, while a third — historically less attractive — had become more interesting because of an unrelated regulatory development. We re-prioritized the target universe accordingly.

We then built and worked through a target list of forty-one companies, narrowed to a working set of nine over six months, and ultimately to three transactions that closed across the following eighteen months. On each, we ran the commercial and operational diligence; on the two larger transactions, we designed and accompanied the integration, with particular attention to the manufacturing consolidation and the retention of the two acquired sales teams.

Throughout, the engagement was structured around the operating team's capacity, not around our own. The platform's CEO and CFO were the decision-makers; we ran the work that the internal team could not have absorbed without compromising the base business.

The platform exited at $310M in revenue, with the three add-ons contributing both topline and meaningful margin expansion through manufacturing and procurement consolidation. The sale process was conducted on the platform's preferred timeline. The integration work held — at the time of exit, retention of the acquired sales teams was 91%, and the manufacturing consolidation had been delivered on plan.

The sponsor's return on the hold was meaningfully above the underwriting case. The platform CEO has retained the firm on subsequent engagements.